Emtriva (emtricitabine) is associate degree antiviral medication that stops human immunological disorder virus (HIV) cells from multiplying in your body.
Emtriva is for treating HIV, that causes the nonheritable immunological disorder syndrome (AIDS). Emtricitabine isn’ta cure for HIV or AIDS.
Emtriva can also be used for functions unlisted during this medication guide.
Submit your review
Get emergency medical help if you have any of these signs of an allergic reaction to Emtriva: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Early symptoms of lactic acidosis may get worse over time and this condition can be fatal. Get emergency medical help if you have even mild symptoms: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired.
Call your doctor at once if you have nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes).
Emtriva may increase your risk of certain infections or autoimmune disorders by changing the way your immune system works. Symptoms may occur weeks or months after you start treatment. Tell your doctor if you have:
signs of a new infection--fever, night sweats, swollen glands, mouth sores, diarrhea, stomach pain, weight loss;
chest pain (especially when you breathe), dry cough, wheezing, feeling short of breath;
cold sores, sores on your genital or anal area;
rapid heart rate, feeling anxious or irritable, weakness or prickly feeling, problems with balance or eye movement;
trouble speaking or swallowing, severe lower back pain, loss of bladder or bowel control; or
swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence, loss of interest in sex.
Common Emtriva side effects may include:
headache, mild dizziness, strange dreams;
mild diarrhea, mild nausea, upset stomach;
darkened patches of skin on your palms and/or soles;
mild skin rash; or
change in the shape or location of body fat (especially in the arms, legs, face, neck, breasts, and trunk).
Adult Patients (18 years of age and older) EMTRIVA capsules: one 200 mg capsule administered once daily orally. EMTRIVA oral solution: 240 mg (24 mL) administered once daily orally. Pediatric Patients (0–3 months of age) EMTRIVA oral solution: 3 mg per kg administered once daily orally. Pediatric Patients (3 months through 17 years) EMTRIVA oral solution: 6 mg per kg up to a maximum of 240 mg (24 mL) administered once daily orally. EMTRIVA capsules: for children weighing more than 33 kg who can swallow an intact capsule, one 200 mg capsule administered once daily orally.